SflomosGeorgios Switzerland

Having dedicated over two decades to conducting fundamental and translational research, specifically on solid tumor malignancies, I possess extensive expertise as a molecular oncology researcher. Over the past years, my focus has been on the most common special histological breast cancer subtype, a highly hormone-sensitive form known as invasive Lobular Breast Carcinoma. My drive stems from a deep passion for uncovering hidden biological phenomena in translational preclinical oncology. My expertise lies in pioneering preclinical cancer models, particularly ER-positive breast cancers, addressing this subtype's lack of clinically relevant preclinical models. I have made significant preclinical advancements, including developing a transformative in vivo intraductal model that closely replicates patient responses to treatments and metastasis characterized by the scientific community as a game-changing. Additionally, I have pioneered innovative experimental methods and tools that have broadened the scope of preclinical and translational research in Lobular Breast Cancer. My work has earned recognition in the research community, with invitations to conferences and collaboration requests. Im curious to explore more about #preclinical models #Breastcancer #metastases #optimized in vivo preclinical models #tumor microenvironment # extracellular matrix #tissue microstructures #2D and #3D tumor models #tumor explants #organoids #Invasive Lobular Carcinoma #endocrine resistance #drug discovery #metastasis #heterogeneity #plasticity